Pan J. Chen
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 121 publications
LARS2 reprograms mitochondrial metabolism and epigenetically upregulates MHC-I to boost antitumor immunity in nasopharyngeal carcinoma.
Journal: Journal for immunotherapy of cancer
Published: August 05, 2026
CT-Derived Body Composition and Early Changes Predict Outcomes of First-Line Chemo-Immunotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma.
Journal: The oncologist
Published: June 20, 2026
Retraction notice to "Extracellular HMGB1 prevents necroptosis in acute myeloid leukemia cells" [Biomedicine & Pharmacotherapy 112 (2019) 108714].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 17, 2026
Efficacy and prognostic analysis of induction chemoimmunotherapy in unresectable stage Ⅲ non-small cell lung cancer: a single-center retrospective study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 16, 2026
An Integrated Prediction Framework for Engineered Cementitious Composite: EDFrame.
Journal: Materials (Basel, Switzerland)
Published: February 27, 2026
Timing of immune checkpoint inhibitors infusion and prognosis in recurrent/metastatic nasopharyngeal carcinoma: a single-center, retrospective study.
Journal: Cancer immunology, immunotherapy : CII
Published: January 27, 2026
Arecoline upregulates CD155 expression to facilitate immune evasion in oral squamous cell carcinoma.
Arecoline upregulates CD155 expression to facilitate immune evasion in oral squamous cell carcinoma.
Journal: Journal for immunotherapy of cancer
Published: November 15, 2025
Targeting mitochondrial homeostasis as a cancer treatment strategy: current status and future prospects.
Journal: Molecular cancer
Published: September 28, 2025
Targeting mitochondrial homeostasis as a cancer treatment strategy: current status and future prospects.
Journal: Molecular cancer
Published: September 28, 2025
Last Updated: 09/26/2026